A relational agent for treating substance use in adults: Protocol for a randomized controlled trial with a psychoeducational comparator.

Journal: Contemporary clinical trials
PMID:

Abstract

BACKGROUND: Substance use disorders (SUDs) are prevalent and compromise health and wellbeing. Scalable solutions, such as digital therapeutics, may offer a population-based strategy for addressing SUDs. Two formative studies supported the feasibility and acceptability of the relational agent Woebot, an animated screen-based social robot, for treating SUDs (W-SUDs) in adults. Participants randomized to W-SUDs reduced their substance use occasions from baseline to end-of-treatment (EOT) relative to a waitlist control.

Authors

  • Judith J Prochaska
    Stanford Prevention Research Center, Department of Medicine, School of Medicine, Stanford University, United States of America. Electronic address: jpro@stanford.edu.
  • Erin A Vogel
    Stanford Prevention Research Center, Department of Medicine, School of Medicine, Stanford University, United States of America.
  • Amy Chieng
    Stanford Prevention Research Center, Department of Medicine, School of Medicine, Stanford University, United States of America.
  • Michael Baiocchi
    Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.
  • Sarah Pajarito
    Woebot Health, United States of America.
  • Maddison Pirner
    Woebot Health, United States of America.
  • Alison Darcy
    Woebot Health, San Francisco, California.
  • Athena Robinson
    Woebot Health, San Francisco, California.